Skip to main content

Want a detailed portfolio tracker?

Estrella Immunopharma (ESLA) P/E (2023 - 2026)

Estrella Immunopharma (ESLA) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM Estrella Immunopharma (ESLA) P/E is -2.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Estrella Immunopharma (ESLA)

YearP/EChange
2026-2.06-43.58%
2025-3.65-25.95%
2024-4.92-76.44%
2023-20.89N/A

Comparison Estrella Immunopharma (ESLA) P/E with competitors

Estrella Immunopharma (ESLA) P/E is -2.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.64%
FGENFibroGen Inc0.24-111.67%
CHRSCoherus Biosciences Inc0.85-141.26%
FBIOFortress Biotech Inc0.95-146.14%
ORMPOramed Pharmaceuticals Inc1.50-173.08%
AGENAgenus Inc3.01-246.34%
INVAInnoviva Inc3.15-253.36%
VXRTVaxart Inc3.55-272.60%
CRMDCorMedix Inc3.63-276.43%
CVACCureVac N.V.4.45-316.16%
GLPGGalapagos NV4.86-336.25%
SRPTSarepta Therapeutics Inc4.88-337.38%
ABEOAbeona Therapeutics Inc5.39-361.96%
ABUSArbutus Biopharma Corp5.60-372.07%
ZVRAZevra Therapeutics Inc5.89-386.25%
SPROSpero Therapeutics Inc6.23-402.84%
CGENCompugen Ltd6.31-407.00%
RIGLRigel Pharmaceuticals6.87-434.14%
SLXNSilexion Therapeutics Corp7.30-454.76%
OMEROmeros Corporation9.26-550.19%
AUPHAurinia Pharmaceuticals Inc9.58-566.05%
PLXProtalix BioTherapeutics Inc10.89-629.55%
ACADAcadia Pharmaceuticals Inc11.73-670.28%
TBPHTheravance Biopharma Inc12.26-696.22%
ADMAAdma Biologics Inc12.42-703.81%
HRMYHarmony Biosciences Holdings Inc13.82-771.98%
SABSSAB Biotherapeutics Inc14.14-787.34%
NAGENiagen Bioscience Inc14.82-820.50%
INCYIncyte Corp15.82-869.34%
REGNRegeneron Pharmaceuticals Inc15.86-871.00%
PBYIPuma Biotechnology Inc17.32-941.94%
CPRXCatalyst Pharmaceuticals Inc17.44-947.95%
EXELExelixis Inc17.54-952.75%
TGTXTG Therapeutics Inc18.97-1022.19%
MDXGMimedx Group Inc20.55-1099.33%
XOMAXOMA Royalty Corp22.87-1212.27%
ARGXArgen X SE24.30-1281.47%
CTMXCytomX Therapeutics Inc24.82-1306.91%
XOMAOXOMA Royalty Corp25.34-1332.37%
HALOHalozyme Therapeutics Inc25.62-1345.94%
XOMAPXOMA Royalty Corp25.67-1348.19%
VRTXVertex Pharmaceuticals Inc27.99-1461.23%
RPRXRoyalty Pharma plc - Class A28.69-1494.91%
SLNOSoleno Therapeutics Inc29.02-1510.85%
ASNDAscendis Pharma A/S30.09-1562.89%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1943.45%
APLSApellis Pharmaceuticals Inc39.02-1997.38%
BMRNBiomarin Pharmaceutical Inc42.21-2152.52%
KRYSKrystal Biotech Inc45.34-2304.80%
ONCBeiGene Ltd69.54-3481.36%
PHARPharming Group N.V.75.03-3748.07%
TECHBio-Techne Corp101.96-5057.66%
VCELVericel Corp109.92-5444.86%
ALNYAlnylam Pharmaceuticals Inc117.96-5835.98%
GMABGenmab140.29-6921.55%
TLXTelix Pharmaceuticals Ltd162.15-7984.58%
CORTCorcept Therapeutics Inc212.86-10450.06%